SUBRETINAL NEOVASCULARIZATION IN MACULAR TELANGIECTASIA TYPE 2: OPTICAL COHERENCE TOMOGRAPHIC ANGIOGRAPHY AND TREATMENT RESPONSE

Retin Cases Brief Rep. 2015 Fall;9(4):286-9. doi: 10.1097/ICB.0000000000000191.

Abstract

Purpose: To report the optical coherence tomographic angiography findings and response to treatment in a case of macular telangiectasia Type 2 with subretinal neovascularization.

Methods: Case report.

Results: A 64-year-old man with macular telangiectasia Type 2 developed subretinal neovascularization, which was imaged on optical coherence tomographic angiography. He was treated with intravitreal aflibercept, and there was a remarkable reduction of flow in the subretinal neovascular network on optical coherence tomographic angiography.

Conclusion: Optical coherence tomographic angiography provides detailed information on the retinal microvasculature and subretinal neovascularization in macular telangiectasia Type 2. It can be used to assess response to treatment.

Publication types

  • Case Reports

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use
  • Fluorescein Angiography*
  • Humans
  • Macula Lutea / pathology
  • Male
  • Middle Aged
  • Receptors, Vascular Endothelial Growth Factor / therapeutic use
  • Recombinant Fusion Proteins / therapeutic use
  • Retinal Neovascularization / diagnosis*
  • Retinal Neovascularization / drug therapy
  • Retinal Neovascularization / etiology
  • Retinal Telangiectasis / complications*
  • Retinal Telangiectasis / drug therapy
  • Tomography, Optical Coherence*

Substances

  • Angiogenesis Inhibitors
  • Recombinant Fusion Proteins
  • aflibercept
  • Receptors, Vascular Endothelial Growth Factor